In the present study, we performed a fine-mapping of the region to define the causal variant responsible for the association with MS susceptibility, and to identify the effect of this variant on the splicing, transcription and expression of the L3MBTL3 gene. Here, L3MBTL3 is linked to myeloid sarcoma.